Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current challenges in antibiotic resistance.

W L Hand1

  • 1Departments of Research Development and Medicine, Texas Tech University Health Sciences Center-El Paso, El Paso, Texas 79905, USA.

Adolescent Medicine (Philadelphia, Pa.)
|August 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes.

International journal of antimicrobial agents·2001
Same author

Influence of pentoxifylline and its derivatives on antibiotic uptake and superoxide generation by human phagocytic cells.

Antimicrobial agents and chemotherapy·1995
Same author

Interactions of dirithromycin with human polymorphonuclear leukocytes.

Antimicrobial agents and chemotherapy·1993
Same author

Role of phospholipase D-derived diradylglycerol in the activation of the human neutrophil respiratory burst oxidase. Inhibition by phosphatidic acid phosphohydrolase inhibitors.

Journal of immunology (Baltimore, Md. : 1950)·1992
Same author

Uptake of antibiotics by human polymorphonuclear leukocyte cytoplasts.

Antimicrobial agents and chemotherapy·1990
Same author

Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes.

Antimicrobial agents and chemotherapy·1990

The rise in bacterial antibiotic resistance, particularly in common pathogens like Streptococcus pneumoniae and Staphylococcus aureus, poses a significant global health threat. This antimicrobial resistance complicates infection treatment and is largely driven by extensive antibiotic use.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antibiotic resistance in bacteria is a growing global concern, especially among common gram-positive coccal pathogens.
  • Key resistant organisms include penicillin-resistant Streptococcus pneumoniae, vancomycin-resistant Enterococcus, and methicillin-resistant Staphylococcus aureus, all exhibiting multidrug resistance.
  • Resistance mechanisms involve altered cell wall-binding sites (beta-lactam and vancomycin resistance) and extended-spectrum beta-lactamase production in gram-negative bacilli.

Purpose of the Study:

  • To discuss the mechanisms, epidemiology, clinical importance, treatment, and prevention of antibiotic resistance.
  • To highlight the challenges posed by multidrug-resistant gram-positive cocci and gram-negative bacilli to antimicrobial therapy.
  • To identify the extensive and inappropriate use of antibiotics as the primary driver of emerging antimicrobial resistance.

Related Experiment Videos

Main Methods:

  • Review and synthesis of existing literature on antibiotic resistance mechanisms.
  • Epidemiological analysis of the spread of resistant bacterial strains.
  • Discussion of clinical implications and therapeutic strategies for managing resistant infections.

Main Results:

  • Antibiotic resistance in common pathogens significantly complicates or prevents effective antimicrobial treatment.
  • Altered cell wall-binding sites and beta-lactamase production are key resistance mechanisms.
  • Extensive and inappropriate antibiotic usage worldwide is the principal factor driving the emergence and dissemination of resistance.

Conclusions:

  • The increasing prevalence of antibiotic resistance necessitates a comprehensive approach to treatment and prevention.
  • Understanding microbial resistance mechanisms is crucial for developing new therapeutic strategies.
  • Global efforts to curb inappropriate antibiotic use are essential to mitigate the threat of antimicrobial resistance.